Abstract

Fourteen new compounds were isolated from marine-derived Streptomyces sp. DS52, including 12 pyrimidine nucleosides (1-12), 1 benzoic acid derivative (13), and 1 dipyridine derivative (14). Additionally, 28 known compounds (15-42) were identified. The structures of all compounds were elucidated through extensive analysis of nuclear magnetic resonance spectroscopic and high-resolution electrospray ionization mass spectroscopy data. Electronic circular dichroism (ECD) calculations were employed to investigate the configurations of compounds 1, 2, and 4-13. Bioactivity evaluations of all of the compounds showed that compound 41 exhibited significant cytotoxicity against the HCT-116 and MDA-MB-231 human cancer cell lines with IC50 values of 0.73±0.06 and 1.11±0.06µM, respectively. Notably, compounds 6, 7, 9, 11, 15, 33-38, 41, and 42 exhibited cytotoxicity against HCT-116 human colon cancer cell lines and MDA-MB-231 human breast cancer cell lines, with IC50 values ranging from 0.73±0.06 to 17.44±0.53µM and from 1.11±0.06 to 18.51±3.07µM, respectively.

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.